NCT03967405View on ClinicalTrials.gov

A Prospective Evaluation of Clinical Equivalence Between iX and PID

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

March 15, 2021

Study Completion Date

March 15, 2021

Conditions
Wound
Interventions
DEVICE

MolecuLight PID

Hand-held, real-time fluorescence imaging device

Trial Locations (1)

M2R 1N5

Judy Dan Research and Treatment Center, North York

Sponsors

Lead Sponsor

MolecuLight Inc.
All Listed Sponsors
lead

MolecuLight Inc.

INDUSTRY

NCT03967405 - A Prospective Evaluation of Clinical Equivalence Between iX and PID | Biotech Hunter | Biotech Hunter